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BRIEF TITLE
One-Year Mortality After Bariatric Surgery
PRECIS
The 1-year mortality rate after contemporary laparoscopic Roux-en-Y gastric bypass and 
laparoscopic sleeve gastrectomy is much lower than previously reported. Older age, higher body 
mass index, and the presence of 30-day leak and pulmonary embolus increase the odds of 1-year 
mortality.
INTRODUCTION
The risk of death after bariatric surgery has been decreasing over the past two decades since 
the introduction of laparoscopic bariatric surgery. Early (30-day) mortality after bariatric 
surgery is now a relatively rare event with contemporary rates typically <0.2%. (1–4) In a 
study examining the mortality rate in patients who underwent bariatric surgery over an 8-
year period, Nguyen and colleagues (5) reported that the in-hospital mortality rate for 
bariatric operations decreased from 0.4% in 2002 to 0.06% in 2009. Factors leading to 
reduction of mortality over time include transitioning from open to laparoscopic bariatric 
surgery (5, 6), initiation of laparoscopic bariatric surgery training by national societies (7), 
implementation of a national bariatric surgery accreditation system (8, 9), and improvement 
in surgeons’ skills after overcoming the learning curve for bariatric surgery (10).
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Most studies examining the risk of mortality after bariatric surgery have been limited to 
either in-hospital or 30-day data, which may underrepresent the true risk of bariatric surgery. 
(11–14) In a study examining early mortality among Medicare beneficiaries who underwent 
open bariatric surgery between 1997–2002, Flum and colleagues (11) found that the 30-day 
and 1-year mortality were vastly different at 2.0% and 4.6%, respectively. In a study 
examining mortality after laparoscopic and open bariatric operations performed in Veterans 
Affairs Medical Centers, Arterburn and colleagues (12) similarly reported a high 30-day and 
1-year mortality of 1.3% and 3.4%, respectively. These studies suggest that about 60% of 
deaths within the first year following bariatric surgery occur after 30 days, meaning the true 
risk of mortality after bariatric surgery may be beyond the 30-day mark and better evaluated 
out to one year after surgery. Additionally, the high 1-year mortality rates reported from 
these studies may represent outcomes from the era of open bariatric surgery. However, few 
studies have examined 1-year mortality after contemporary laparoscopic bariatric surgery 
within the past decade. (15, 16)
The Bariatric Outcomes Longitudinal Database (BOLD) was initiated in 2007 by the 
American Society of Metabolic and Bariatric Surgery (ASMBS) with a unique aspect of 
reporting of 1-year outcomes, providing the opportunity to examine 1-year mortality after 
contemporary laparoscopic bariatric surgery. The aim of this study was to use the BOLD to 
examine 30-day and 1-year mortality rates, as well as risk factors for 1-year mortality after 
contemporary laparoscopic bariatric surgery.
METHODS
Data Source
The BOLD is managed by the ASMBS and contains HIPAA-compliant, patient-level data 
prospectively collected from over 700 centers participating in the ASMBS Bariatric Surgery 
Centers of Excellence program. The ASMBS and the American College of Surgeons 
Bariatric Surgery Center Network merged their respective bariatric accreditation programs in 
2012 to form the Metabolic and Bariatric Surgery Accreditation and Quality Improvement 
Program (MBSAQIP). At that time, the BOLD was discontinued and a more refined 
MBSAQIP database was started. However, the BOLD database was selected for use in this 
study because it contains data from accredited bariatric centers with 1-year outcomes after 
index bariatric operations, whereas MBSAQIP data are limited to 30-day outcomes.
This study was exempt from Institutional Review Board approval, as the BOLD contains 
only de-identified patient data and any specific patient intervention or interaction was not 
possible.
Data Analysis
All patients who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB) or 
laparoscopic sleeve gastrectomy (LSG) between 2008–2012 were examined. To control for 
the effect of the type of procedure on outcomes, data were analyzed separately according to 
whether LRYGB or LSG was performed. Open cases were excluded. The primary outcome 
of interest was the mortality rate within one year after a patient’s index bariatric operation.
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Statistical Analysis
Statistical analysis was performed using SAS version 9.4 (SAS Institute, Cary, NC). 
Multivariate logistic regression was used to determine the adjusted odds ratio (AOR) for the 
association between 1-year mortality and patients’ demographics; comorbidities; and the 
presence of major complications including 30-day leak, 30-day pulmonary embolism (PE), 
and 30-day hemorrhage. The statistical analysis was limited to these three complications as 
they were the only variables available for specific complications. Other complications were 
grouped as a composite endpoint that included mortality, and hence could not be used in our 
model to determine risk factors for mortality. A parsimonious model was then obtained 
using backward selection of variables with P < 0.1 from the multivariate logistic regression 
model. Results were reported as AOR with 95% confidence intervals (CI). Patients with 
missing preoperative condition variables were excluded from the regression analysis. Two-
sided tests with P < 0.05 were considered statistically significant.
RESULTS
Data on 158,606 laparoscopic bariatric operations were examined, including 128,349 
(80.9%) LRYGB and 30,257 (19.1%) LSG procedures. Patient demographics and 
comorbidities are summarized in Table 1. For patients undergoing LRYGB, mean age was 
45.5 (standard deviation, SD, 11.7) years old; race was predominately Caucasian (71.8%); 
mean body mass index (BMI) was 47.5 (SD 8.1) kg/m2; and the most common preoperative 
comorbidities included hypertension (54.8%), obstructive sleep apnea (43.4%), depression 
(36.4%), and diabetes (32.9%). For patients undergoing LSG, mean age was 44.6 (SD 11.3) 
years old; race was predominately Caucasian (68.3%); mean BMI was 46.4 (SD 8.6) kg/m2; 
and the most common preoperative comorbidities included hypertension (50.4%), 
obstructive sleep apnea (39.7%), depression (31.7%), and diabetes (27.1%).
Outcomes after LRYGB and LSG are summarized in Table 2. For LRYGB, the 30-day 
mortality rate was 0.13%, and the 1-year mortality rate was 0.23%, representing a 76.9% 
relative increase. Among the 294 cases of 1-year mortality, 124 (42.2%) occurred between 
30 days and 1 year after surgery. Postoperative rates of 30-day leak, PE, and hemorrhage 
were 0.45%, 0.16%, and 1.54%, respectively. For LSG, the 30-day mortality rate was 0.06%, 
and the 1-year mortality rate was 0.11%, representing an 83.3% relative increase. Among the 
32 cases of 1-year mortality, 17 (53.1%) occurred between 30 days and 1 year after surgery. 
Postoperative rates of 30-day leak, PE, and hemorrhage were 0.26%, 0.11%, and 0.59%, 
respectively.
Table 3 lists patients’ demographics, comorbidities, and the presence of 30-day 
complications, along with their associated odds of 1-year mortality after laparoscopic 
bariatric surgery after adjustment for all covariates. A parsimonious model was then 
obtained using backward selection of variables with P < 0.1 from the multivariate logistic 
regression model, with results as listed in Table 4. For LRYGB, significant risk factors 
independently associated with higher odds of 1-year mortality included older age (AOR 1.05 
per year; P < 0.001); male gender (AOR 1.88; P < 0.001); higher BMI (AOR 1.04 per unit; P 
< 0.001); history of venous thromboembolism (VTE; AOR 2.04; P = 0.006); any functional 
impairment (i.e., bedridden or needing an assistance device to mobilize; AOR 1.76; P = 
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0.003); and the presence of 30-day leak (AOR 25.4; P < 0.001), 30-day PE (AOR 34.5; P < 
0.001), and 30-day hemorrhage (AOR 2.34; P = 0.001). For LSG, significant risk factors 
independently associated with higher odds of 1-year mortality included older age (AOR 1.08 
per year; P < 0.001); higher BMI (AOR 1.05 per unit; P = 0.009); and the presence of 30-
day leak (AOR 35.8; P < 0.001) or 30-day PE (AOR 252.0; P < 0.001). For both LRYGB 
and LSG, the effect of substance abuse on death could not be determined, as none of the 
patients with a history of substance abuse died in this series.
DISCUSSION
In this study examining the outcomes of contemporary laparoscopic bariatric surgery 
performed at Bariatric Surgery Centers of Excellence, we found an overall low risk of 30-
day mortality (0.13% for LRYGB and 0.06% for LSG) that increased by 1.8-fold by one 
year (0.23% for LRYGB and 0.11% for LSG). Factors associated with higher 1-year 
mortality included older age; higher BMI; and the presence of 30-day leak and PE for both 
LRYGB and LSG. For LRYGB specifically, other factors associated with higher 1-year 
mortality included male gender, any functional impairment, history of VTE, and the 
presence of 30-day hemorrhage.
The most important finding from the current study is the low contemporary 1-year mortality 
rate after laparoscopic bariatric surgery, which is much lower than previously reported. Prior 
studies examining open and laparoscopic bariatric surgery have reported 1-year mortality 
rates ranging between 0.38%−4.6%. (11, 12, 15, 16) In a study of bariatric surgeries 
recorded in Swedish national registries between 1980–2010, Tao and colleagues (15) 
reported a low 1-year mortality of 0.38%. In a study examining outcome of open and 
laparoscopic gastric bypass in the state of California between 1995 and 2009, Weiss and 
colleagues (16) reported a 1-year mortality rate of 2.2%. Flum and colleagues (11) reported 
a 1-year mortality rate as high as 4.6% in their study on over 16,000 patients who underwent 
bariatric surgery from 1997–2002. The low 1-year mortality of 0.11–0.23% in the current 
study is likely multifactorial. One contributing factor may be the transition from open to 
laparoscopic bariatric surgery, which has been shown to be associated with lower mortality. 
(5, 6) Additionally, the implementation of training programs by national societies to 
minimize the learning curve of laparoscopic bariatric surgery may also account for the 
decreased mortality over time. (7, 10) Furthermore, the development of the bariatric surgery 
accreditation system may have also contributed to the reduction in mortality rates, since 
accredited centers in bariatric surgery have been shown to have improved outcomes 
compared to nonaccredited centers. (8, 9)
Our study also confirmed that limiting analysis to 30-day mortality significantly 
underestimates the mortality rate after laparoscopic bariatric surgery. For LRYGB, 42.2% of 
the mortality events within the first year of surgery occurred after 30 days. Similarly, for 
LSG, 53.1% of the mortality events within the first year occurred after 30 days. This is 
consistent with the finding that limiting analysis to 30 days after bariatric surgery excludes 
about 60% of mortality events that occur within the first year after surgery. (11–13) 
Furthermore, in a study examining mortality after bariatric surgery using a Pennsylvania 
statewide database, Omalu and colleagues (13) found that deaths due to traumatic causes 
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(i.e., motor vehicle accidents, homicides, falls, suicides, drug overdoses) comprised only 
10% of the mortality events recorded over a nine-year period. This suggests that the majority 
of deaths occurring after 30 days are due to complications of surgery or underlying 
comorbidities, and that evaluating 1-year mortality may provide a more accurate picture of 
the true risk of bariatric surgery. The higher 1-year mortality rates also suggest that patients 
would benefit from comprehensive, long-term follow-up, such as is required by the 
MBSAQIP for accreditation of bariatric centers. This calls into question the 2013 decision 
by Medicare to reverse the National Coverage Determination that required bariatric centers 
to be accredited to serve Medicare beneficiaries. Without accreditation, there is no formal, 
mandatory review process to ensure that Medicare patients receive long-term follow-up after 
bariatric surgery, which may place them at undue risk of long-term complications.
Factors associated with increased odds of 1-year mortality after LRYGB in this study 
include older age, male gender, and higher BMI. These findings are consistent with results 
from previously published studies on mortality after laparoscopic bariatric surgery (Table 5). 
Additionally, our study identified that a history of VTE and impaired functional status are 
both independently associated with higher 1-year mortality. We also found that the presence 
of 30-day leak, PE, and hemorrhage events were associated with increased odds of 1-year 
mortality after LRYGB. In a study examining the effect of short-term complications on early 
mortality in 580 LRYGB cases, Fernandez and colleagues (17) similarly found that the 
presence of postoperative leak and PE were associated with higher early mortality. The 
effect of postoperative hemorrhage on the risk of mortality was not assessed in that study.
Few studies have examined risk factors for mortality after LSG. In an American College of 
Surgeons National Surgical Quality Improvement Program (NSQIP) study, 5,871 LSG cases 
were used to develop a risk calculator for serious adverse events that was then validated in a 
series of 3,130 cases from the same database. (1) The authors found that 30-day serious 
adverse events were correlated with male gender (OR 1.68; 95% CI 1.03–2.72) and 
increased BMI (OR 1.03; 95% CI 1.01–1.05), along with various other preoperative 
comorbidities. In our study, which has a similar population of patients undergoing LSG, we 
likewise found an association between higher BMI and increased odds of 1-year mortality 
(AOR 1.05 per unit; P = 0.013). We also found that the presence of 30-day complications 
including leak and PE were associated with an increase in odds of 1-year mortality.
A final point to note is the discrepancy between the large number of LRYGB cases 
compared to LSG cases performed in the current study. One possible reason that over four 
times as many LRYGB cases were performed is that the learning curve for LRYGB was 
reaching a plateau during the study period, whereas the curve for LSG was still developing. 
In a study using the Nationwide Inpatient Sample from 2008–2012, a time period similar to 
the one used in the current study, Khan et al (18) found that the percentage of LRYGB cases 
increased from 58.2% of total bariatric cases in 2008 to a peak of 63.2% in 2009, and then 
decreased to 49.4% by 2012. In contrast, the authors showed that the percentage of LSG 
cases increased from 8.2% in 2011 to 39.6% in 2012. Similarly, the percentage of LRYGB 
cases in the current study decreased from 95.3% in 2008 to 62.6% in 2012, while the 
percentage of LSG cases increased from 4.7% in 2008 to 37.4% in 2012. This suggests a 
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transition from LRYGB toward LSG over the study period, a trend that has been 
demonstrated in a number of other recent studies. (19–21)
There are several limitations to our study. First, this was a retrospective study based on a 
national database and was thus subject to possible selection bias, inaccurate data input, 
coding errors, and missing data. Secondly, we are unable to determine the actual cause of 
death and whether it was related to the index bariatric operation. Despite these limitations, 
this study included a large sample size from a national cohort of patients. In addition, 
analysis in this study was stratified by type of procedure, either LRYBG or LSG, allowing us 
to control for both the effect of operative approach (i.e., no open cases were analyzed that 
could influence our results) and the effect of procedure type. In addition, our study is one of 
few that have analyzed risk factors for mortality out to one year after laparoscopic bariatric 
surgery, allowing us to include a significant percentage of patients who are not evaluated in 
analyses limited to short-term outcomes.
CONCLUSION
The risk of 1-year mortality after contemporary laparoscopic bariatric surgery is much lower 
than previously reported, likely due to overcoming the learning curve of laparoscopic 
surgery, the development of specialized bariatric training programs, and the establishment of 
an accreditation program for bariatric surgery. It is important to continually refine surgical 
techniques and perioperative management in order to minimize leaks and pulmonary emboli 
after laparoscopic bariatric surgery, as these complications increase the risk for mortality. In 
addition, limiting the analysis of mortality to a 30-day endpoint may underrepresent the true 
risk of mortality after laparoscopic bariatric surgery. Future studies should consider using 1-
year mortality as a more meaningful and accurate endpoint for analysis of outcomes after 
laparoscopic bariatric surgery.
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AOR adjusted odds ratio
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BMI body mass index
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LRYGB laparoscopic Roux-en-Y gastric bypass
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MBSAQIP Metabolic and Bariatric Surgery Accreditation and Quality 
Improvement Program
NSQIP National Surgical Quality Improvement Program
PE pulmonary embolism
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Table 1.
Patient Demographics and Characteristics According to Type of Procedure
Characteristic LRYGB (n = 128,349) LSG (n = 30,257)
Age, y, mean (SD) 45.5 (11.7) 44.6(11.3)
Age, y, median (IQR) 45.0 (37–54) 44.0 (36–53)
Female sex, n (%) 57,944 (77.5) 13,757 (75.2)
Race, n (%)
Caucasian 92,111 (71.8) 20,675 (68.3)
Hispanic 10,879 (8.48) 2,959 (9.78)
African American 14,841 (11.6) 3,748 (12.4)
Other 10,518 (8.19) 2,875 (9.50)
BMI, m/kg2, mean (SD) 47.5 (8.10) 46.4 (8.60)
BMI, m/kg2, median (IQR) 46.0 (41.7–51.7) 44.7 (40.4–50.7)
ASA Class, n (%)
I 3,512 (2.74) 996 (3.29)
II 27,989 (21.8) 8,828 (29.2)
III 91,150 (71.0) 19,548 (64.6)
IV 5,698 (4.44) 885 (2.92)
Comorbidities
Congestive heart disease 2,560 (2.01) 440 (1.47)
Depression 46,452 (36.4) 9,516 (31.7)
Diabetes 41,958 (32.9) 8,134 (27.1)
Hypertension 69,831 (54.8) 15,122 (50.4)
Ischemic heart disease 3,511 (2.75) 622 (2.07)
Liver disease 9,020 (7.07) 1,654 (5.51)
Sleep apnea 55,378 (43.4) 11,916 (39.7)
Peripheral vascular disease 1,432 (1.12) 278 (0.93)
Venous thromboembolism 2,346 (1.83) 435 (1.44)
Any functional impairment 4,351 (3.41) 672 (2.24)
Alcohol use 17,597 (13.8) 5,469 (18.2)
Tobacco use 6,196 (4.86) 1,494 (4.98)
Substance abuse 383 (0.30) 75 (0.25)
Values are presented as frequencies (%) unless otherwise indicated.
ASA, American Society of Anesthesiologists; IQR, interquartile range; LRYGB, laparoscopic Roux-en-Y gastric bypass; LSG, laparoscopic sleeve 
gastrectomy.
J Am Coll Surg. Author manuscript; available in PMC 2019 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Inaba et al. Page 10
Table 2.
Operative Outcomes According to Type of Procedure
Outcome LRYGB (n = 128,349) LSG (n = 30,257)
n % n %
30-d Leak 575 (0.45) 80 (0.26)
30-d Pulmonary embolus 208 (0.16) 33 (0.11)
30-d Hemorrhage 1,979 (1.54) 179 (0.59)
30-d Mortality 170 (0.13) 17 (0.06)
1-y Mortality 294 (0.23) 32 (0.11)
Values are presented as frequencies (%) unless otherwise indicated.
LRYGB, laparoscopic Roux-en-Y gastric bypass; LSG, laparoscopic sleeve gastrectomy
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Table 3.
Factors Predictive of 1-Year Mortality after Laparoscopic Bariatric Surgery According to Type of Procedure, 
Multivariate Logistic Regression Model
Variable LRYGB LSG
AOR 95% CI p
value
AOR 95% CI p
value
Age, per 1-year increase 1.05 (1.04, 1.07) <0.001 1.08 (1.04, 1.13) <0.001
Male gender (ref: Female) 1.93 (1.50, 2.48) <0.001 1.39 (0.63, 3.06) 0.416
Race (ref: Caucasian)
Hispanic 1.16 (0.71, 1.88) 0.554 0.67 (0.09, 5.21) 0.703
African American 1.28 (0.89, 1.86) 0.184 2.08 (0.74, 5.82) 0.163
Other 1.22 (0.79, 1.86) 0.368 0.89 (0.23, 3.46) 0.865
BMI, per 1-unit increase 1.04 (1.03, 1.05) <0.001 1.05 (1.01, 1.08) 0.013
ASA Class (ref: Class I)
II 0.69 (0.29, 1.66) 0.409 0.24 (0.04, 1.36) 0.106
III 0.81 (0.35, 1.84) 0.610 0.21 (0.04, 0.99) 0.048
IV 1.67 (0.70, 4.02) 0.249 2.34 (0.46, 11.7) 0.304
Comorbidities (ref: absence of comorbidity)
Congestive heart disease 1.25 (0.72, 2.16) 0.431 0.67 (0.08, 5.57) 0.713
Depression 1.09 (0.85, 1.39) 0.523 1.07 (0.47, 2.44) 0.868
Diabetes 0.91 (0.70, 1.18) 0.478 0.68 (0.29, 1.59) 0.379
Hypertension 1.29 (0.98, 1.69) 0.067 1.36 (0.58, 3.18) 0.477
Ischemic heart disease 0.95 (0.56, 1.60) 0.846 2.74 (0.77, 9.75) 0.120
Liver disease 0.82 (0.50, 1.35) 0.438 2.88 (0.95, 8.77) 0.062
Sleep apnea 1.09 (0.85, 1.39) 0.500 1.00 (0.45, 2.18) 0.989
Peripheral vascular disease 1.28 (0.61, 2.67) 0.512 0.88 (0.09, 8.27) 0.913
Venous thromboembolism 2.00 (1.19, 3.34) 0.008 0.88 (0.09, 7.42) 0.844
Any functional impairment 1.71 (1.17, 2.50) 0.005 1.07 (0.28. 4.05) 0.922
Alcohol use 0.81 (0.56, 1.18) 0.276 1.10 (0.40, 3.04) 0.852
Tobacco use 1.47 (0.90, 2.41) 0.126 1.95 (0.44, 8.57) 0.375
Complications, 30d (ref: no
complication)
Leak 24.67 (16.7, 36.6) <0.001 37.25 (8.50, 163.2) <0.001
Pulmonary embolus 33.73 (20.5, 55.7) <0.001 233.5 (60.4, 901.9) <0.001
Hemorrhage 2.30 (1.37, 3.86) 0.002 6.47 (1.05, 39.7) 0.044
AOR, adjusted odds ratio; ASA, American Society of Anesthesiologists; BMI, body mass index; CI, confidence interval; LRYGB, laparoscopic 
Roux-en-Y gastric bypass; LSG, laparoscopic sleeve gastrectomy; ref, reference
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Table 4.
Factors Predictive of 1-Year Mortality after Laparoscopic Bariatric Surgery According to Type of Procedure, 
Parsimonious Model*
Variable LRYGB LSG
AOR 95% CI p-value AOR 95% CI p-value
Age, per 1-year increase 1.05 (1.04, 1.07) <0.001 1.08 (1.04, 1.13) <0.001
Male gender (ref: Female) 1.88 (1.48, 2.40) <0.001 -- -- --
BMI, per 1-unit increase 1.04 (1.03, 1.05) <0.001 1.05 (1.01, 1.08) 0.009
ASA Class III
Comorbidities (ref: absence of
comorbidity)
Hypertension 1.29 (1.00, 1.66) 0.050 -- -- --
Liver disease -- -- -- 2.88 (0.98, 8.50) 0.055
Venous thromboembolism 2.04 (1.23, 3.38) 0.006 -- -- --
Functional status--any impairment 1.76 (1.21, 2.56) 0.003 -- -- --
Complications, 30d (ref: no
complication)
Leak 25.4 (17.2, 37.5) <0.001 35.8 (8.61, 157.3) <0.001
Pulmonary embolism 34.5 (20.9, 56.8) <0.001 252 (71.0, 895.2) <0.001
Hemorrhage 2.34 (1.39, 3.92) 0.001 5.24 (0.88, 31.4) 0.070
*
Parsimonious model was obtained using backward selection of variables with P < 0.1 from the multivariate logistic regression model
AOR, adjusted odds ratio; ASA, American Society of Anesthesiologists; BMI, body mass index; CI, confidence interval; LRYGB, laparoscopic 
Roux-en-Y gastric bypass; LSG, laparoscopic sleeve gastrectomy; PE, pulmonary embolism; ref, reference
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Table 5.
Summary of Selected Studies Published over the Last Decade Examining Risk Factors for Mortality After 
Laparoscopic Roux-en-Y Gastric Bypass and/or Laparoscopic Sleeve Gastrectomy
Procedure,
article
Database Groups
Studied
Group size
n
Mortality
rate, %
(follow-
up time)
Risk factors for
mortality
LRYGB or
LSG
analyzed as
separate
groups
Current Study BOLD 2008–2012 LRYGB
LSG
N = 128,349
N = 30,257
0.23% (1 y)
0.11% (1 y)
Both: older age, higher BMI, 30-d leak, 
30-day PE, 30-day hemorrhage
LRYGB only: male gender, history of 
VTE, decreased functional status
Morton 2014 (22) BOLD 2007–2010 LRYGB N = 51,788 0.1% (30 d) Age ≥ 50; male gender; BMI 50–70; 
comorbidities ≥ 5; LOS 0, 0/1, or 4
Aminian 2015 (1) NSQIP 2012 LSG N = 5871 0.05% (30 d) Male sex, higher BMI, CHF, chronic 
steroid use, DM, preoperative serum 
total bilirubin level, preoperative 
hematocrit level
LRYGB or
LSG
analyzed in
combination
with other
bariatric
procedures
Morino 2007 (23) SICOB Registry 1996–2006 LRYGB+
ORYGB
N = 1106 0.54% (60 d) Laparoscopic-to-open conversion, HTN
Arterburn 2009 (12) VAMC NSQIP 2000–2006 LRYGB +
ORYGB +
LAGB+ OAGB
+ LSG + VBG +
OSG + other
N = 856 1.3% (30 d)
2.1% (90 d)
3.4% (1 y)
BMI ≥ 50, Diagnostic Cost Group 
score ≥ 2, open approach
Nguyen 2011 (24) NIS 2006–2008 LRYGB + ORYGB 
+ LAGB + VBG
N = 304,515 0.12% (inpatient) Age > 50, male gender, CHF, CRF, 
PVD, open vs. laparoscopic approach, 
gastric bypass vs. other bariatric 
procedures
Dorman 2012 (25) NSQIP 2005–2009 LRYGB + ORYGB 
+ LAGB + VBG + 
BPD-DS
Laparoscopic:
N = 43,361 
Open:
N = 5,017
0.15% (30 d) Laparoscopic bariatric procedures only: 
BMI ≥ 60, male gender, DM, cardiac 
comorbidities
Open bariatric procedures only: BMI ≥ 
60
Ramanan 2012 (26) NSQIP 2006–2008 LRYGB + ORYGB 
+ LAGB + VBG + 
BPD-DS + other
N = 21,891 0.14% (30 d) Older age, higher BMI, PVD, dyspnea, 
previous PCI, chronic steroid use, type 
of bariatric procedure
Khan 2013 (27) NSQIP 2007–2009 LRYGB + ORYGB 
+ LAGB + VBG + 
BPD-DS
N = 44,408 0.14% (30 d) Age > 45, BMI > 50, male gender, 
DM, totally dependent functional 
status, PCI, dyspnea, >10% weight loss 
in 6 mo, bleeding disorder, open vs. 
laparoscopic approach
Nguyen 2013 (28) UHC database 2002–2009 LRYGB + ORYGB 
+ LAGB + VBG
N = 105,287 0.17% (inpatient) Age > 60, male gender, Medicare 
payer, DM, open approach, gastric 
bypass vs. nongastric bypass bariatric 
procedure
Benotti 2014 (3) BOLD 2007–2011 LRYGB+ ORYGB N = 81,751 0.15% (30 d) Older age, male gender, higher BMI, 
pulmonary HTN, CHF, liver disease
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Procedure,
article
Database Groups
Studied
Group size
n
Mortality
rate, %
(follow-
up time)
Risk factors for
mortality
Tao 2015 (15) Swedish Patient Registry 
1980–2010
LRYGB + ORYGB 
+ LAGB + VBG + 
BPD-DS + other
N = 22,487 0.38% (1 y) Male gender, CHF, DM, open approach
Telem 2015 (29) SPARCS 1999–2005 LRYGB + LAGB 
+ VBG + sleeve 
gastrectomy
N = 7862 2.5% (8–14 y) Older age, male gender, Medicare/ 
Medicaid payment source, CHF, HTN, 
DM, chronic pulmonary disorder, 
rheumatoid arthritis
Lazzati 2016 (4) French National Health 
Service Database 2007–2012
LRYGB + ORYGB 
+ LAGB + OAGB 
+ LSG + OSG
N = 133,804 0.12% (90 d) Age >50, BMI > 50, male gender, DM, 
HTN, open approach, procedure type, 
lower procedure volume
Weiss 2016 (16) California OSHPD 1995–2009 LRYGB + ORYGB N = 129,432 2.2% (1 y);
4.4% (5 y);
8.1% (10 y)
Older age, male gender, open approach, 
DM, smoker, alcohol abuse, higher 
Charlson Index, insurance status, LOS 
< 4 or ≥ 7
ASA, American Society of Anesthesiologists; BMI, body mass index; BOLD, Bariatric Outcomes Longitudinal Database; CAD, coronary artery 
disease; CHF, congestive heart failure; CRF, chronic renal failure; DM, diabetes mellitus; HTN, hypertension; LAGB, laparoscopic adjustable 
gastric banding; LOS, length of stay; LRYGB, laparoscopic Roux-en-Y gastric bypass; LSG, laparoscopic sleeve gastrectomy; NIS, National 
Inpatient Sample; NSQIP, National Surgical Quality Improvement Program; OAGB, open adjustable gastric banding; ORYGB, open Roux-en-Y 
gastric bypass; OS-MRS, Obesity Surgery Mortality Risk Score; OSG, open sleeve gastrectomy; OSHPD, Office of Statewide Health Planning and 
Development; PCI, percutaneous coronary intervention; PE, pulmonary embolus; PVD, peripheral vascular disease; SICOB, Italian Society of 
Obesity Surgery; SPARCS, New York Statewide Planning and Research Cooperative System; UHC, University HealthSystem Consortium; VAMC, 
Veterans Affairs Medical Centers; VBG, vertical banded gastroplasty; VTE, venous thromboembolism
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